Business Insider7d
JMP Securities Remains a Hold on Boyd Gaming (BYD)
JMP Securities analyst Jordan Bender maintained a Hold rating on Boyd Gaming (BYD – Research Report) today. The company’s shares closed yesterday at $78.57. Leverage the power of TipRanks ...
Business Insider4d
JMP Securities Reaffirms Their Buy Rating on nCino (NCNO)
In a report released today, Aaron Kimson from JMP Securities maintained a Buy rating on nCino (NCNO – Research Report), with a price target of $43.00. The company’s shares opened today at $32.81.
Investing9d
Alphabet shares drop following JMP Securities rating
This movement came in the wake of a reiteration of a Market Perform rating by JMP Securities, with the firm maintaining its stance on the stock's outlook. The decline comes as the stock trades ...
Business Insider8d
JMP Securities Reaffirms Their Hold Rating on Ares Management (ARES)
JMP Securities analyst Brian McKenna maintained a Hold rating on Ares Management (ARES – Research Report) today. The company’s shares closed yesterday at $189.65. Leverage the power of ...
Business Insider4d
JMP Securities Reaffirms Their Buy Rating on Atricure (ATRC)
In a report released today, Daniel Stauder from JMP Securities reiterated a Buy rating on Atricure (ATRC – Research Report), with a price target of $60.00. The company’s shares closed last ...
Business Insider8d
JMP Securities Reaffirms Their Hold Rating on Essex Property (ESS)
In a report released today, Aaron Hecht from JMP Securities reiterated a Hold rating on Essex Property (ESS – Research Report). The company’s shares closed yesterday at $295.79. Leverage the ...
Business Insider8d
JMP Securities Remains a Buy on Workday (WDAY)
JMP Securities analyst Patrick Walravens maintained a Buy rating on Workday (WDAY – Research Report) today and set a price target of $315.00. The company’s shares closed yesterday at $276.17.
ETF Daily News4d
JMP Securities Reiterates “Market Outperform” Rating for Protagonist Therapeutics (NASDAQ:PTGX)
JMP Securities reiterated their market outperform rating on shares of Protagonist Therapeutics (NASDAQ:PTGX – Free Report) in a research report report published on Friday,Benzinga reports.
ETF Daily News4d
Cytokinetics (NASDAQ:CYTK) Given Market Outperform Rating at JMP Securities
JMP Securities restated their market outperform rating on shares of Cytokinetics (NASDAQ:CYTK – Free Report) in a research note released on Friday morning,Benzinga reports. JMP Securities ...
Business Insider7d
JMP Securities Remains a Hold on Omega Healthcare (OHI)
In a report released today, Aaron Hecht from JMP Securities reiterated a Hold rating on Omega Healthcare (OHI – Research Report). The company’s shares closed yesterday at $38.06. Leverage the ...
Business Insider7d
JMP Securities Reaffirms Their Buy Rating on Haemonetics (HAE)
In a report released today, David Turkaly from JMP Securities maintained a Buy rating on Haemonetics (HAE – Research Report), with a price target of $100.00. The company’s shares closed ...
Business Insider8d
JMP Securities Sticks to Its Hold Rating for Western Union (WU)
In a report released today, David Scharf from JMP Securities maintained a Hold rating on Western Union (WU – Research Report). The company’s shares closed yesterday at $11.01. Leverage the ...